| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2738 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2354 | 2020 |
| Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I A Puel, R Döffinger, A Natividad, M Chrabieh, G Barcenas-Morales, ... Journal of Experimental Medicine 207 (2), 291-297, 2010 | 845 | 2010 |
| Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants A Belkadi, A Bolze, Y Itan, A Cobat, QB Vincent, A Antipenko, L Shang, ... Proceedings of the National Academy of Sciences 112 (17), 5473-5478, 2015 | 757 | 2015 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells L de Beaucoudrey, A Puel, O Filipe-Santos, A Cobat, P Ghandil, ... The Journal of experimental medicine 205 (7), 1543-1550, 2008 | 516 | 2008 |
| Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries L De Beaucoudrey, A Samarina, J Bustamante, A Cobat, ... Medicine 89 (6), 381-402, 2010 | 457 | 2010 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 385 | 2021 |
| Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery EM Scott, A Halees, Y Itan, EG Spencer, Y He, MA Azab, SB Gabriel, ... Nature genetics 48 (9), 1071-1076, 2016 | 378 | 2016 |
| Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome AY Kreins, MJ Ciancanelli, S Okada, XF Kong, N Ramírez-Alejo, SS Kilic, ... Journal of Experimental Medicine 212 (10), 1641-1662, 2015 | 374 | 2015 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia Q Zhang, P Bastard, A Cobat, JL Casanova Nature 603 (7902), 587-598, 2022 | 286 | 2022 |
| A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection JL Casanova, HC Su, L Abel, A Aiuti, S Almuhsen, AA Arias, P Bastard, ... Cell 181 (6), 1194-1199, 2020 | 272 | 2020 |
| Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia B Boisson, E Laplantine, K Dobbs, A Cobat, N Tarantino, M Hazen, ... Journal of Experimental Medicine 212 (6), 939-951, 2015 | 269 | 2015 |
| Loss of B cells in patients with heterozygous mutations in IKAROS HS Kuehn, B Boisson, C Cunningham-Rundles, J Reichenbach, ... New England Journal of Medicine 374 (11), 1032-1043, 2016 | 265 | 2016 |
| Exome and genome sequencing for inborn errors of immunity I Meyts, B Bosch, A Bolze, B Boisson, Y Itan, A Belkadi, V Pedergnana, ... Journal of Allergy and Clinical Immunology 138 (4), 957-969, 2016 | 232 | 2016 |
| Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis A Cobat, CJ Gallant, L Simkin, GF Black, K Stanley, J Hughes, TM Doherty, ... Journal of Experimental Medicine 206 (12), 2583-2591, 2009 | 201 | 2009 |
| Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant S Boisson-Dupuis, N Ramirez-Alejo, Z Li, E Patin, G Rao, G Kerner, ... Science immunology 3 (30), eaau8714, 2018 | 197 | 2018 |
| Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds C Prando, A Samarina, J Bustamante, S Boisson-Dupuis, A Cobat, ... Medicine 92 (2), 109-122, 2013 | 186 | 2013 |
| Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine P Bastard, E Michailidis, HH Hoffmann, M Chbihi, T Le Voyer, J Rosain, ... Journal of Experimental Medicine 218 (4), e20202486, 2021 | 182 | 2021 |
| Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines N Hernandez, G Bucciol, L Moens, J Le Pen, M Shahrooei, E Goudouris, ... Journal of Experimental Medicine 216 (9), 2057-2070, 2019 | 172 | 2019 |
